Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Oropharyngeal Neoplasms 2Uveal Melanoma 1Parotid Neoplasms 1Neoplasms 1Motor Activity 1Head and Neck Neoplasms 1Breast Neoplasms 1Anal Intraepithelial Neoplasia 1

Interventions

Ipilimumab 3Triamcinolone Acetonide 2Ranibizumab 2Nivolumab 2Amplified Fragment Length Polymorphism Analysis 2treosulfan 1salicylhydroxamic acid 1aldesleukin 1Ultrasonography 1Tramadol 1Temozolomide 1Tamoxifen 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Sorafenib 1Rose Bengal 1Radiosurgery 1Physical Examination 1Pharmacogenomic Testing 1Interviews as Topic 1Immunotherapy 1Ibuprofen 1Gemcitabine 1Eye Enucleation 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Uveal Melanoma × Physical Examination × Clear all
NCT06280040 2024-03-06

Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma

Medical University of Vienna

Unknown
20 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡